Taurine Supplementation in Long COVID
Taurine Supplementation in Long COVID
Recruiting · NCT06721949 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Taurine Supplementation in Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 / Phase 3 | 2026-09-18 | NCT06721949 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| University Health Network, Toronto | 417 |
| University of Alberta | 249 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Women's Hospital | Vancouver | Canada | 4 |
| Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke | Sherbrooke | Canada | 1 |
| Institut de recherches cliniques de Montréal | Montreal | Canada | 1 |
| University Health Network | Toronto | Canada | 19 |
| University of Alberta Hospital, Kaye Edmonton Clinic | Edmonton | Canada | 1 |